Group One Trading’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3649 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3514 |
|
|
2022
Q4 | – | Sell |
-2,334
| Closed | -$5K | – | 3558 |
|
|
2022
Q3 | $5K | Buy |
+2,334
| New | +$5K | ﹤0.01% | 1715 |
|
|
2022
Q2 | – | Sell |
-2,250
| Closed | -$15K | – | 3603 |
|
|
2022
Q1 | $15K | Sell |
2,250
-10,428
| -82% | -$69.5K | ﹤0.01% | 1701 |
|
|
2021
Q4 | $106K | Buy |
12,678
+8,400
| +196% | +$70.2K | ﹤0.01% | 1380 |
|
|
2021
Q3 | $32K | Buy |
4,278
+2,500
| +141% | +$18.7K | ﹤0.01% | 1646 |
|
|
2021
Q2 | $12K | Sell |
1,778
-2,350
| -57% | -$15.9K | ﹤0.01% | 1753 |
|
|
2021
Q1 | $42K | Buy |
+4,128
| New | +$42K | ﹤0.01% | 1414 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2831 |
|
|
2020
Q3 | – | Sell |
-3,760
| Closed | -$26K | – | 2692 |
|
|
2020
Q2 | $26K | Sell |
3,760
-3,601
| -49% | -$24.9K | ﹤0.01% | 1035 |
|
|
2020
Q1 | $35K | Sell |
7,361
-5,834
| -44% | -$27.7K | ﹤0.01% | 900 |
|
|
2019
Q4 | $115K | Buy |
13,195
+10,954
| +489% | +$95.5K | ﹤0.01% | 775 |
|
|
2019
Q3 | $7K | Sell |
2,241
-2,366
| -51% | -$7.39K | ﹤0.01% | 1139 |
|
|
2019
Q2 | $23K | Sell |
4,607
-12,040
| -72% | -$60.1K | ﹤0.01% | 937 |
|
|
2019
Q1 | $103K | Buy |
16,647
+16,468
| +9,200% | +$102K | ﹤0.01% | 627 |
|
|
2018
Q4 | $1K | Sell |
179
-42,300
| -100% | -$236K | ﹤0.01% | 1318 |
|
|
2018
Q3 | $276K | Buy |
+42,479
| New | +$276K | ﹤0.01% | 588 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 2164 |
|
|
2018
Q1 | – | Sell |
-568
| Closed | -$7K | – | 2083 |
|
|
2017
Q4 | $7K | Buy |
+568
| New | +$7K | ﹤0.01% | 1211 |
|